Michelle Carnahan, Arbiter CEO: From Eli Lilly to solving healthcare's $100B fragmentation crisis
Chrissy Farr sits down with Michelle Carnahan, who spent 26 years at Eli Lilly witnessing the development of breakthrough GLP-
Chrissy Farr sits down with Michelle Carnahan, who spent 26 years at Eli Lilly witnessing the development of breakthrough GLP-
Real, unfiltered interviews with the leaders who refuse to quit on healthcare.
Big Tech companies have long viewed healthcare as one of the last major industries ready for disruption. With a $4
This week’s news and headlines unpacked, plus a Q&A with Jacquelyn Miller
Happy weekend! I write to you as I’m returning from the West Coast, where I witnessed the renaissance of
RCM is about to hit its fourth - and potentially final phase
From GLP-1 pricing to cash-pay care, the system is shifting toward a leaner, consumer-driven future — one that rewards those who rethink what insurance is for.
This week’s news and headlines unpacked, plus a Q&A with Rushika Fernandopulle
5 principles for patient-facing AI, according to top clinicians
It’s not a good moment to be a health insurer - unless you’re Cigna (at least for now)
What a whirlwind week at HLTH! This is an abnormally jam packed edition because of how much news was announced
A recently-published analysis shows that provider pricing in the commercial market is essentially random, and there’s no correlation to quality